RE:Year End Q4 financials Yes - Q4 financials and Update.
I would assume an update focuses is on OTENA - hopefully comments on both acute and chronic.
As for IBD - we might hear a patent application has occurred - if the stress test went well.
We likely have the pills now - fingers crossed
Planning for PK/PD - this is likely key for acute and chronic planning
That's what I'd expect ... with the focus being OTENA. That's the real story here, with Acute looking like a no-brainer on the 5-day regimen side.
Cake walk or crushed pills ? To be determined ... hahaha !